Wine consumption falls heavily into the red
Worldwide consumption of wine fell in 2024 to its lowest level in more than 60 years, the main trade body said Tuesday, raising concerns about new risks from US tariffs.
The International Organisation of Vine and Wine (OIV) said that 2024 sales fell 3.3 percent from the previous year to 214.2 million hectolitres.
The OIV, whose report was based on government figures, said this would be the lowest sales figure since 1961, when sales were 213.6 million hl.
Production is also at its lowest level in more than 60 years, having fallen 4.8 percent in 2024 to 225.8 million hl.
OIV statistics chief Giorgio Delgrosso said the wine industry had been hit by a perfect storm with health concerns driving down consumption in many countries while economic factors had added to troubles.
"Beyond the short-term economic and geopolitical disruptions," said the IOV's annual report, "it is important to consider the structural, long-term factors also contributing to the observed decline in wine consumption."
The OIV said that the consumer is now paying about 30 percent more for a bottle now than in 2019-2020 and overall consumption has fallen by 12 percent since then.
The United States, the world's top wine market, saw consumption fall 5.8 percent to 33.3 million hl.
Delgrosso said that tariffs ordered by US President Donald Trump, even though temporarily suspended, could become "another bomb" for the wine industry.
Sales in China remain below pre-Covid-19 levels, despite a rebound since the pandemic.
Europe, which accounts for nearly half of worldwide sales, saw consumption fall 2.8 percent last year. Even in France, one of the key global producers, 3.6 percent less wine was knocked back last year.
Spain and Portugal were among rare markets where consumption increased.
The OIV said production had been hit environmental extremes such as above average rainfall in some key regions and droughts in others.
Italy was the world's top producer with 44 million hl, while France's output fell 23 percent to 36.1 million hl, its lowest level since 1957.
Italy is also the biggest wine exporter and its trade increased because of the popularity of sparkling wines such as Prosecco.
Spain produced 31 million hl, while US wine output fell 17.2 percent to 21.1 million hl, mainly because of extreme heat.
The OIV could not predict if consumption would take off again and wine industry players, such as the French retail chain Nicolas say there is a "generational" fall in drinking.
"People do not drink in a festive way anymore and young people consume less than their parents," the company said in a statement to AFP.
But it added, "people drink less, but better" and so are ready to spend more.
cho/ebl/tw/giv
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
38 minutes ago
- Yahoo
Bessent says US may 'roll the date forward' for some after 90-day tariff pause ends
(Reuters) -U.S. Treasury Secretary Scott Bessent on Wednesday said the Trump administration is prepared to "roll the date forward" with trading partners negotiating in good faith if the deadline marking the end of the 90-day pause on President Donald Trump's reciprocal tariffs is reached with no deal. "It is highly likely that those countries - or trading blocs as is the case with the EU - who are negotiating in good faith, we will roll the date forward to continue the good-faith negotiations," Bessent told the House Ways and Means Committee. "If someone is not negotiating, then we will not." Bessent's remarks, in response to a question from a Democratic lawmaker, marked the first time a Trump administration official has indicated some flexibility around the expiration date for the pause. That date - July 8 - is now just four weeks away, and so far the White House has struck only one preliminary deal with a major foreign trading partner affected by the pause, Britain. A deal struck on Tuesday in London with China to de-escalate that bilateral trade war is proceeding on a separate track and timeline. The White House did not immediately respond to a question about whether Trump shared Bessent's view. Trump announced the pause on April 9, a week after unveiling "Liberation Day" tariffs against nearly all U.S. trading partners that proved to be so unexpectedly large and sweeping that it sent global financial markets into near panic. The S&P 500 Index plunged more than 12% in four days for its heftiest run of losses since the onset of the COVID-19 pandemic in early 2020. Investors were so rattled they bailed out of safe-haven U.S. Treasury securities, sending bond yields rocketing higher. The dollar sank. Markets started their recovery on April 9 when Trump unexpectedly announced the pause. A further leg up in the recovery followed in early May when the Trump team reached a preliminary deal to dial back the triple-digit tariff rates it had imposed on goods from China. The events have given rise to what some on Wall Street have parodied as the "TACO" trade - an acronym for Trump Always Chickens Out. "The only time the market has reacted positively is when the administration is in retreat from key policy areas," Democratic Representative Don Beyer of Virginia told Bessent before pressing him on what should be expected at the end of the next deadline next month. "As I have said repeatedly there are 18 important trading partners. We are working toward deals with those," Bessent said before going on to signal a willingness to offer extensions to those negotiating in good faith. (Reporting By Dan Burns; Editing by Chris Reese and Daniel Wallis)
Miami Herald
38 minutes ago
- Miami Herald
AMC makes major theater change that will frustrate customers
AMC Theaters (AMC) had a rough start to 2025. The theater chain suffered a major loss as it struggled to attract moviegoers, despite major releases such as "Captain America: Brave New World," "Snow White," "Wolf Man," and "Dog Man." In its first-quarter earnings report for 2025, AMC revealed that its total revenues fell by about 9% year-over-year, while movie theater attendance in the U.S. dropped by 11%. Don't miss the move: Subscribe to TheStreet's free daily newsletter AMC also reported a net loss of $202.1 million during the quarter, which is higher than the $163.5 million net loss it suffered during the same quarter last year. Related: AMC announces generous offer to win back customers "Setting aside those first quarters directly impacted by Covid and its aftermath, the January to March industry box office in 2025 was the lowest it has been since 1996," said AMC CEO Adam Aron in the report. The dip in attendance comes after AMC's average movie ticket price in the U.S. reached $12.31 during the first quarter of this year, which is higher than the $12.19 average it reported for the same quarter in 2024. Movie ticket prices have been rising over the past few years amid inflation. According to recent data from The Numbers, the average movie ticket price in the U.S. was $11.31 in 2024, which is 3% higher than the $10.94 average in 2023. As prices increase, some consumers have been avoiding movie theaters like the flu. A recent survey from the Wall Street Journal found that 65% of consumers said they prefer to watch movies at home, while 35% said they prefer to watch films in theaters. Amid this trend, AMC has made a bold move to dodge further price increases; however, customers may not be thrilled about the decision. The theater chain has reportedly landed a deal with cinema advertising company National CineMedia to run more commercials before movie screenings begin, according to a recent report from The New York Times. AMC claims this deal will allow it to rely less on increasing movie ticket prices to boost its revenue. Related: Paramount makes drastic decision amid shift in customer behavior "For the past five years, AMC has sought out crucial revenue that is not reliant on the increase of base ticket prices," said AMC in a statement to the Times, adding "while AMC was initially reluctant to bring this to our theaters, our competitors have fully participated for more than five years without any direct impact to their attendance." The move from AMC comes after its top rivals, Regal and Cinemark, signed the same deal with National CineMedia in 2019. AMC was also offered the deal that same year; however, it "flatly rejected" it due to its concerns that "U.S. moviegoers would react quite negatively to the concept," according to a press release. The deal is expected to make pre-show advertisements last, on average, 20 to 30 minutes long. It is no surprise that AMC is continuing to dodge increasing its ticket prices as it has recently made several attempts to make moviegoing more affordable for consumers, who are battling inflation and higher costs of living. A few months ago, the theater chain added a new A-List Classic tier subscription to its flagship subscription service AMC Stubs A-List. The new tier offers a lower-price plan for guests who prefer to watch a maximum of one movie per week at AMC Classic locations. It also made several tweaks to AMC Stubs A-List to attract more frugal customers, such as expanding A-List weekly movie access from three titles a week to four, and lowering the age eligibility from 16 to 13 to attract more teens and families into theaters. During an earnings call in May, Aron said these changes are "designed to ease the pain of a healthy price increase." Related: Disney CEO offers unexpected response to tariff concerns The Arena Media Brands, LLC THESTREET is a registered trademark of TheStreet, Inc.
Yahoo
an hour ago
- Yahoo
AIM ImmunoTech Announces 1-for-100 Reverse Stock Split
OCALA, Fla., June 11, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (OTC Pink: AIMID) (NYSE American: AIM) ('AIM' or the 'Company') today announced a reverse stock split ('Reverse Stock Split') of its shares at a ratio of 1-for-100. The Reverse Stock Split will take effect at market open tomorrow, June 12, 2025. The Company's ticker symbol on the OTC Pink will be AIMID for 20 trading days, including the effective date. One of the primary goals of the Reverse Stock Split is to increase the per-share market price of the Company's common stock to enable the Company to regain compliance with the NYSE American's Listing Qualifications. At a Special Meeting of Stockholders held on April 30, 2025, the Company's stockholders approved a series of alternate amendments to the Company's Certificate of Incorporation to effect a reverse stock split of the Company's outstanding common stock at a ratio in the range of up to 1-for-100, with such ratio to be determined by the Company's Board of Directors. Stockholders will be given cash in lieu of any fractional shares on a post-split basis. Following the Reverse Stock Split, the new CUSIP number of the common stock will be 00901B303, with the par value per share of common stock remaining at $0.001. About AIM ImmunoTech Inc. AIM ImmunoTech Inc. is an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders and viral diseases, including COVID-19. The Company's lead product is a first-in-class investigational drug called Ampligen® (rintatolimod), a dsRNA and highly selective TLR3 agonist immuno-modulator with broad spectrum activity in clinical trials for globally important cancers, viral diseases and disorders of the immune system. For more information, please visit and connect with the Company on X, LinkedIn, and Facebook. Cautionary Statement This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the 'PSLRA'). Words such as 'may,' 'will,' 'expect,' 'plan,' 'anticipate,' 'continue,' 'believe,' 'potential,' 'upcoming' and other variations thereon and similar expressions (as well as other words or expressions referencing future events or circumstances) are intended to identify forward-looking statements. Many of these forward-looking statements involve a number of risks and uncertainties. Data, pre-clinical success and clinical success seen to date do not guarantee that Ampligen will be approved as a therapy in any indication. The Company urges investors to consider specifically the various risk factors identified in its most recent Form 10-K, and any risk factors or cautionary statements included in any subsequent Form 10-Q or Form 8-K, filed with the U.S. Securities and Exchange Commission. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Among other things, for those statements, the Company claims the protection of the safe harbor for forward-looking statements contained in the PSLRA. The Company does not undertake to update any of these forward-looking statements to reflect events or circumstances that occur after the date hereof. CONTACT: Investor Contact: JTC Team, LLC Jenene Thomas 908.824.0775 AIM@
